Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis

被引：2

作者：

Leong, Stanley P. ^{[1
,2
]}

Nathanson, S. David ^{[3
,4
]}

Zager, Jonathan S. ^{[5
,6
]}

机构：

[1] Calif Pacific Med Ctr Res Inst, San Francisco, CA 94107 USA

[2] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA

[3] Henry Ford Hlth, Dept Surg, 2799 W Grand Blvd, Detroit, MI 48202 USA

[4] Henry Ford Hlth, Canc Ctr, Detroit, MI USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA

[6] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Tampa, FL USA

来源：

CLINICAL & EXPERIMENTAL METASTASIS | 2024年 / 41卷 / 04期

关键词：

Lymphovascular; Cancer metastasis; Molecular mechanisms;

D O I：

10.1007/s10585-024-10272-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：271 / 273

页数：3

共 7 条

[1]

[Anonymous], 2023, CLIN EXP METASTAS

[2] Epigenetic Changes in Cancer [J].

Iacobuzio-Donahue, Christine A. .

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :229-249

[3]

Leong SP, 2022, CANC METASTASIS LYMP

[4] Novel frontiers in detecting cancer metastasis [J].

Leong, Stanley P. ;

Ballesteros-Merino, Carmen ;

Jensen, Shawn M. ;

Marwitz, Sebastian ;

Bifulco, Carlo ;

Fox, Bernard A. ;

Skoberne, Mojca .

CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (5-6) :403-412

[5] Cancer neoantigens as potential targets for immunotherapy [J].

Ma, Weijie ;

Pham, Brian ;

Li, Tianhong .

CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (01) :51-60

[6] Mutation burden as a potential prognostic marker of melanoma progression and survival. [J].

Simpson, Danny ;

Ferguson, Robert ;

Martinez, Carlos N. ;

Kazlow, Esther ;

Moran, Una ;

Heguy, Adriana ;

Hanniford, Douglas ;

Hernando, Eva ;

Osman, Iman ;

Kirchhoff, Tomas .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[7] Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine? [J].

Steuer, Conor E. ;

Ramalingam, Suresh S. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07) :631-U7

← 1 →